NovoCure's Depreciation & Amortization (CF) rose 4902.36% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.5 million, marking a year-over-year increase of 2470.98%. This contributed to the annual value of $11.2 million for FY2024, which is 242.5% up from last year.
According to the latest figures from Q3 2025, NovoCure's Depreciation & Amortization (CF) is $3.7 million, which was up 4902.36% from $3.4 million recorded in Q2 2025.
In the past 5 years, NovoCure's Depreciation & Amortization (CF) ranged from a high of $3.7 million in Q3 2025 and a low of $2.4 million during Q1 2021
Its 5-year average for Depreciation & Amortization (CF) is $2.8 million, with a median of $2.7 million in 2023.
As far as peak fluctuations go, NovoCure's Depreciation & Amortization (CF) crashed by 1230.82% in 2024, and later skyrocketed by 4902.36% in 2025.
Quarter analysis of 5 years shows NovoCure's Depreciation & Amortization (CF) stood at $2.7 million in 2021, then rose by 1.24% to $2.7 million in 2022, then increased by 0.85% to $2.7 million in 2023, then grew by 13.99% to $3.1 million in 2024, then increased by 18.01% to $3.7 million in 2025.
Its last three reported values are $3.7 million in Q3 2025, $3.4 million for Q2 2025, and $3.3 million during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value